Key result
Intramyocardial hemorrhage is linked to adverse post-ischemic outcomes but lacks prospective validation.
Why the study?
Most clinical evidence on intramyocardial hemorrhage remains observational, and management guided by intramyocardial hemorrhage has not yet been prospectively validated.
Intramyocardial hemorrhage is a severe post-ischemic injury detectable by CMR that correlates with adverse remodeling and outcomes, representing a potential target for future phenotype-directed therapies.
IMH marks severe post-MI microvascular injury with adverse outcomes; leaves open whether CMR-guided therapies alter prognosis.
Intramyocardial hemorrhage (IMH) is a severe form of post-ischemic microvascular injury that may occur after myocardial infarction, particularly in the setting of extensive ischemia and reperfusion. IMH is closely related to microvascular obstruction (MVO), larger infarct size, impaired left-ventricular (LV) function, and adverse clinical outcomes. Cardiovascular magnetic resonance (CMR), especially susceptibility-sensitive techniques such as T2* or R2* mapping, enables in vivo detection of hemorrhagic microvascular injury and may refine post-MI risk stratification. Mechanistic and translational studies suggest that erythrocyte degradation and infarct-core iron deposition may contribute to persistent inflammation, maladaptive healing, adverse remodeling, and possibly arrhythmogenic substrate formation. However, most clinical evidence remains observational, and IMH-guided management has not yet been prospectively validated. This narrative review summarizes current evidence on the pathophysiology, imaging diagnosis, prognostic significance, and emerging therapeutic implications of IMH, while highlighting unresolved questions regarding standardized imaging, clinical implementation, and future phenotype-directed therapies.
No takes yet. Share an insight, caveat, or question.
Chioncel et al. (2026) conducted a review in Intramyocardial hemorrhage after myocardial infarction. Intramyocardial hemorrhage (IMH) was evaluated. Intramyocardial hemorrhage is a severe post-ischemic injury linked to adverse outcomes, though clinical evidence remains observational and lacks prospective validation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: